SCHEMBL21767229

SCHEMBL21767229

NNC(=O)N(N)c1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGG1 O15527 1/20 0.48
IDO1 P14902 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
F13A1 P00488 2/20 0.36
TGM2 P21980 2/20 0.36
LMNA P02545 2/20 0.36
TGM1 P22735 1/20 0.36
TGM3 Q08188 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
GSK3B P49841 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28180042 0.82 CYP3A4 (0.47) LMNAMEN1KMT2ACA1CA2
SCHEMBL28116855 0.80 ALDH1A1 (0.48) CES2CES1LMNAMEN1KMT2A
SCHEMBL28177790 0.80 KDM4E (0.44) CES2CES1TGM2LMNATDP1
SCHEMBL9037566 0.80 ALDH1A1 (0.39) IDO1CES2CES1TGM2MEN1
SCHEMBL6206534 0.79 NPSR1 (0.48) MEN1KMT2ATDP1NPC1HTT
SCHEMBL27842747 0.78 TSHR (0.46) CES2CES1MEN1KMT2ACA1
SCHEMBL27871979 0.78 PARP1 (0.42) OGG1IDO1TGM2NPC1RAB9A
SCHEMBL22251861 0.77 IDO1 (0.43) IDO1LMNAMEN1KMT2AGSK3B
SCHEMBL27467210 0.77 ALDH1A1 (0.45) MEN1KMT2ATDP1HDAC6KDM4E
SCHEMBL27892920 0.77 NPC1 (0.40) LMNAMEN1KMT2AHDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464262-B1 TRIAZOLONES AND TETRAZOLONES AS INHIBITORS OF ROCK BRISTOL MYERS SQUIBB CO (US) 2020-02-26 EP disclosed
CN-106232581-A Non-platinum based anti-cancer compounds for targeted chemotherapy 卢庆彬 2016-12-14 CN disclosed